281235-04-9

Basic information

• Product Name: 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER
• Synonyms: 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER;Methyl 4-(piperidin-4-yl)benzoate;METHYL 4-PIPERIDIN-4-YL-BENZATE HCL;Methyl 4-piperidin-4-yl-benzate
• CAS NO: 281235-04-9
• Molecular Formula: C₁₃H₁₇NO₂
• Molecular Weight: 219.28
• Product Categories: pharmacetical
• Mol File: 281235-04-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 340.3°C at 760 mmHg
• Flash Point: 159.6°C
• Appearance: /
• Density: 1.071g/cm³
• Vapor Pressure: 8.65E-05mmHg at 25°C
• Refractive Index: 1.524
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER(281235-04-9)
• EPA Substance Registry System: 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER(281235-04-9)

Safety Data

• Hazardous Substances Data: 281235-04-9(Hazardous Substances Data)

Usage

General Description

4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER is a chemical compound consisting of a piperidine ring and a benzoic acid moiety connected through an ester linkage. It is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceuticals. 4-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER has potential pharmacological properties and is often utilized as a building block in the development of new medications. Additionally, it may also be used in research laboratories for the study of various biological processes and drug discovery. However, it is important to handle this compound with care as it may have hazardous properties and proper safety precautions should be taken when working with it.

InChI:InChI=1/C13H17NO2/c1-16-13(15)12-4-2-10(3-5-12)11-6-8-14-9-7-11/h2-5,11,14H,6-9H2,1H3

Upstream product

• 286961-15-7 benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1 (2H)-pyridinecarboxylate 
• 586-76-5 4-Bromobenzoic acid 
• 67-56-1 methanol 
• 196204-01-0 4-(piperidin-4-yl)-benzoic acid 
• 936130-82-4 methyl 4-(piperidine-4-yl)benzoate hydrochloride 
• 106047-17-0 4-Pyridin-4-yl-benzoic acid methyl ester 

Downstream Products

• 1035271-37-4 methyl 4-(1-prop-2-enylpiperidin-4-yl)benzoate 
• 354813-48-2 methyl 4-(1-methylpiperidin-4-yl)benzoate 
• 355379-05-4 4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1127500-08-6 4-(1'-cyclopropylmethyl-2'-oxo-3,4,5,6,1',2'-hexahydro-2H-[1,4']bipyridinyl-4-yl)-benzoic acid 
• 1034470-07-9 methyl 4-[1-(4-methyl-3-nitro-benzoyl)-4-piperidyl]benzoate 
• 1001548-02-2 C₁₇H₂₃NO₂ 
• 1001548-00-0 methyl 4-(1-cyclopropylpiperidin-4-yl)benzoate 
• 1001548-24-8 methyl 4-(1-ethylpiperidin-4-yl)benzoate 
• 1001548-01-1 4-(1-cycIobutylpiperidin-4-yl)benzoic acid 
• 1001547-97-2 4-(1-cyclopropylpiperidin-4-yl)benzoic acid 
• 1001547-96-1 4-(1-ethylpiperidin-4-yl)-benzoic acid 
• 1620568-72-0 C₁₉H₂₇N₃O₅ 
• 1620568-63-9 methyl 4-[1-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl]-4-piperidyl]benzoate 
• 1620568-57-1 methyl 4-(1-cyano-4-piperidyl)benzoate 

Relevant articles and documents

BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS

The invention relates to new chemical compounds of Formula (I), pharmaceutical compositions containing them, and their use for the pharmacological treatment of a cancer, preferably a glioblastoma.

NOVEL COMPOUNDS

There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.

Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof

The present invention relates to carboxylic acids and esters of general formula wherein Ar, R, R1, X1, X3, X4, Y and Y1 are defined as in claim 1, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof, as well as the use thereof for the production and purification of antibodies and as labelled compounds in RIA and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.